SH
Shuichiro Higo
Principal Investigator
Osaka University
I'm working on
2 years ago
Therapeutic development for cardiomyopathy using disease model
About
Our research aim
Generation of Human Disease Model Recapitulating Inherited Cardiomyopathy
Development of Upstream Therapy Targeting Molecular Basis of Inherited Cardiomyopathy
Partnering listings
Learn more
Osaka University
AAV-mediated gene replacement therapy for DSG2-related ARVC
Osaka University is developing an AAV-mediated gene replacement therapy targeting DSG2-deficient ARVC. This innovative approach aims to address the genetic cause of ARVC, potentially reducing the need for heart transplan...
TechnologyConceptualUniversity
Osaka University
Human iPSC-derived cardiomyocyte model for inherited cardiomyopathy
Innovative human disease model using iPSC-derived cardiomyocytes to study inherited cardiomyopathy and develop targeted therapies. This model facilitates understanding of molecular causes and aids in the development of n...
TechnologyConceptualUniversity
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.